172 related articles for article (PubMed ID: 38378004)
21. Outcomes of stereotactic body radiotherapy versus lobectomy for stage I non-small cell lung cancer: a propensity score matching analysis.
Lin Q; Sun X; Zhou N; Wang Z; Xu Y; Wang Y
BMC Pulm Med; 2019 May; 19(1):98. PubMed ID: 31118007
[TBL] [Abstract][Full Text] [Related]
22. Clinical Outcomes of Stereotactic Body Radiotherapy for Patients With Stage I Small-Cell Lung Cancer: Analysis of a Subset of the Japanese Radiological Society Multi-Institutional SBRT Study Group Database.
Shioyama Y; Onishi H; Takayama K; Matsuo Y; Takeda A; Yamashita H; Miyakawa A; Murakami N; Aoki M; Matsushita H; Matsumoto Y; Shibamoto Y;
Technol Cancer Res Treat; 2018 Jan; 17():1533033818783904. PubMed ID: 29983096
[TBL] [Abstract][Full Text] [Related]
23. Is stereotactic body radiotherapy an alternative to surgery in early stage non small cell lung cancer?
Yaprak G; Ozan Seseogullari O; Dogan Akaslan B; Isik N
J BUON; 2019; 24(4):1619-1625. PubMed ID: 31646817
[TBL] [Abstract][Full Text] [Related]
24. Impact of introducing stereotactic lung radiotherapy for elderly patients with stage I non-small-cell lung cancer: a population-based time-trend analysis.
Palma D; Visser O; Lagerwaard FJ; Belderbos J; Slotman BJ; Senan S
J Clin Oncol; 2010 Dec; 28(35):5153-9. PubMed ID: 21041709
[TBL] [Abstract][Full Text] [Related]
25. Multi-institutional analysis of stereotactic body radiation therapy for operable early-stage non-small cell lung carcinoma.
Kann BH; Verma V; Stahl JM; Ross R; Dosoretz AP; Shafman TD; Gross CP; Park HS; Yu JB; Decker RH
Radiother Oncol; 2019 May; 134():44-49. PubMed ID: 31005223
[TBL] [Abstract][Full Text] [Related]
26. Repeat stereotactic body radiotherapy (SBRT) for local recurrence of non-small cell lung cancer and lung metastasis after first SBRT.
Ogawa Y; Shibamoto Y; Hashizume C; Kondo T; Iwata H; Tomita N; Ogino H
Radiat Oncol; 2018 Jul; 13(1):136. PubMed ID: 30055636
[TBL] [Abstract][Full Text] [Related]
27. Local control for clinical stage I non-small cell lung cancer treated with 5-fraction stereotactic body radiation therapy is not associated with treatment schedule.
Samson P; Rehman S; Juloori A; DeWees T; Roach M; Bradley J; Videtic GMM; Stephans K; Robinson C
Pract Radiat Oncol; 2018; 8(6):404-413. PubMed ID: 29907514
[TBL] [Abstract][Full Text] [Related]
28. Mortality after radiotherapy or surgery in the treatment of early-stage non-small-cell lung cancer: a population-based data analysis in the clinical cancer registry of Brandenburg-Berlin.
Müller JA; Vordermark D; Medenwald D
Strahlenther Onkol; 2023 Jul; 199(7):658-667. PubMed ID: 36912978
[TBL] [Abstract][Full Text] [Related]
29. CT imaging features associated with recurrence in non-small cell lung cancer patients after stereotactic body radiotherapy.
Li Q; Kim J; Balagurunathan Y; Qi J; Liu Y; Latifi K; Moros EG; Schabath MB; Ye Z; Gillies RJ; Dilling TJ
Radiat Oncol; 2017 Sep; 12(1):158. PubMed ID: 28946909
[TBL] [Abstract][Full Text] [Related]
30. Survival of Primary Stereotactic Body Radiation Therapy Compared With Surgery for Operable Stage I/II Non-small Cell Lung Cancer.
Khorfan R; Kruser TJ; Coughlin JM; Bharat A; Bilimoria KY; Odell DD
Ann Thorac Surg; 2020 Jul; 110(1):228-234. PubMed ID: 32147416
[TBL] [Abstract][Full Text] [Related]
31. Effect of Stereotactic Body Radiation Therapy on Diverse Organ Lesions in Advanced Non-Small Cell Lung Cancer Patients Receiving Immune Checkpoint Inhibitors.
Zhu KK; Wei JL; Xu YH; Li J; Rao XR; Xu YZ; Xing BY; Zhang SJ; Chen LC; Dong XR; Zhang S; Li ZY; Liu CW; Meng R; Wu G
Curr Med Sci; 2023 Apr; 43(2):344-359. PubMed ID: 37002471
[TBL] [Abstract][Full Text] [Related]
32. Multi-institutional experience of stereotactic body radiotherapy for large (≥5 centimeters) non-small cell lung tumors.
Verma V; Shostrom VK; Kumar SS; Zhen W; Hallemeier CL; Braunstein SE; Holland J; Harkenrider MM; S Iskhanian A; Neboori HJ; Jabbour SK; Attia A; Lee P; Alite F; Walker JM; Stahl JM; Wang K; Bingham BS; Hadzitheodorou C; Decker RH; McGarry RC; Simone CB
Cancer; 2017 Feb; 123(4):688-696. PubMed ID: 27741355
[TBL] [Abstract][Full Text] [Related]
33. Stereotactic Ablative Radiotherapy for stage I histologically proven non-small cell lung cancer: an Italian multicenter observational study.
Ricardi U; Frezza G; Filippi AR; Badellino S; Levis M; Navarria P; Salvi F; Marcenaro M; Trovò M; Guarneri A; Corvò R; Scorsetti M
Lung Cancer; 2014 Jun; 84(3):248-53. PubMed ID: 24681279
[TBL] [Abstract][Full Text] [Related]
34. Stereotactic Body Radiotherapy for Early-stage Non-small-cell Lung Cancer in Patients 80 Years and Older: A Multi-center Analysis.
Cassidy RJ; Patel PR; Zhang X; Press RH; Switchenko JM; Pillai RN; Owonikoko TK; Ramalingam SS; Fernandez FG; Force SD; Curran WJ; Higgins KA
Clin Lung Cancer; 2017 Sep; 18(5):551-558.e6. PubMed ID: 28373068
[TBL] [Abstract][Full Text] [Related]
35. Response criteria in solid tumors (PERCIST/RECIST) and SUV
Pierson C; Grinchak T; Sokolovic C; Holland B; Parent T; Bowling M; Arastu H; Walker P; Ju A
Radiat Oncol; 2018 Feb; 13(1):34. PubMed ID: 29486779
[TBL] [Abstract][Full Text] [Related]
36. Circulating Tumor Cells Are Associated with Recurrent Disease in Patients with Early-Stage Non-Small Cell Lung Cancer Treated with Stereotactic Body Radiotherapy.
Frick MA; Feigenberg SJ; Jean-Baptiste SR; Aguarin LA; Mendes A; Chinniah C; Swisher-McClure S; Berman A; Levin W; Cengel KA; Hahn SM; Dorsey JF; Simone CB; Kao GD
Clin Cancer Res; 2020 May; 26(10):2372-2380. PubMed ID: 31969332
[TBL] [Abstract][Full Text] [Related]
37. Stereotactic body radiation therapy for re-irradiation of persistent or recurrent non-small cell lung cancer.
Trovo M; Minatel E; Durofil E; Polesel J; Avanzo M; Baresic T; Bearz A; Del Conte A; Franchin G; Gobitti C; Rumeileh IA; Trovo MG
Int J Radiat Oncol Biol Phys; 2014 Apr; 88(5):1114-9. PubMed ID: 24661664
[TBL] [Abstract][Full Text] [Related]
38. [Comparison of Clinical Outcomes of VATS and SBRT in the Treatment of NSCLC].
Wang J; Zuo Z; Zhang H; Li W; Wang K
Zhongguo Fei Ai Za Zhi; 2016 Mar; 19(3):136-46. PubMed ID: 27009818
[TBL] [Abstract][Full Text] [Related]
39. Cost-effectiveness analysis of stereotactic body radiotherapy and surgery for medically operable early stage non small cell lung cancer.
Paix A; Noel G; Falcoz PE; Levy P
Radiother Oncol; 2018 Sep; 128(3):534-540. PubMed ID: 29706462
[TBL] [Abstract][Full Text] [Related]
40. Stereotactic body radiotherapy improves the survival of patients with oligometastatic non-small cell lung cancer.
Ouyang W; Yu J; Nuerjiang S; Li Z; Wang D; Wang X; Zhang J; Xie C
Cancer Med; 2019 Aug; 8(10):4605-4614. PubMed ID: 31245933
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
